Back to home page

Performance

The science that accelerates progress

Beijing
Metropolitan Region

Celebrating Beijing’s role as a global center of impactful oncology and cancer research. The diagrams below chart the city’s scholarly outputs and activities across this critical medical discipline.


Oncology and cancer research output in Beijing grew 277% from 873 publications in 2010 to 3,287 in 2019


100 institutions in Beijing have publications within the disciplines of oncology and cancer research


Between 2010 and 2018 the NSFC awarded 155 million USD in grants to cancer research in Beijing

Publication & Citation Performance
(2010-2019)

Scholarly Output*

22,468

Citations per Publication

17.1

Authors (Globally)

95,364

Field-Weighted Citation Impact**

1.05

*Number of publications indexed in Scopus
**The ratio of the total citations received by the denominator’s output, and the total citations that would be expected based on the average of the subject field

Co-Authored Oncology and Cancer Publications
Within the top 15 Collaborating Institutions in Beijing (2010-2019)

Chinese Academy of Medical Science

Peking University

Capital Medical University

University of Chinese Academy of Sciences

Chinese Academy of Sciences

Ministry of Education, China

Ministry of Health of People’s Republic of China

General Hospital of People’s Liberation Army

CAS - Institute of Biophysics

Academy of Military Medical Science China

Tsinghua University

CAS - Institute of Automation

CAS - Institute of Zoology

Chinese Center for Disease Control and Prevention

Beijing University of Chines Medicine

Industry Impact:
Patents and Patent Citations (2010-2019)

Citing-Patents Count


Number of patents globally citing Beijing’s oncology research

Patent-Cited Scholarly Output


Count of published oncology research from Beijing that was cited by patents

Patent Output


Count of oncology or cancer related patents filed in Beijing with the USPTO* or WIPO**

*patft.uspto.gov; All patents with Applicant or Inventor City from Beijing, and Title or Abstract with keywords “cancer” or “oncology” from 2010 – 2019
**patentscope.wipo.int; All patents with Applicant Address from Beijing, and Title or Abstract with keywords “cancer” or “oncology” from 2010 – 2019
Results from search queries not de-duplicated.

Industry Impact:
Top Corporate Collaborators (2010-2019)

Institution
Co-Authored Publications
SINOPEC
54
AstraZeneca
33
Novartis
31
Merck
27
GlaxoSmithKline
24
Pfizer
23
Leidos Inc
23
Bayer AG
15

Beijing’s Outsized Contribution
to High Prominence Topics in Oncology

Top 3 Largest Topic Clusters in Oncology by Beijing’s Output (2010-2019)

MicroRNAs; Long Untranslated RNA

Beijing Share of Topic Globally*

2.3%

Share of Beijing Oncology and Cancer Research**

8.67%

FWCI of Beijing Research in this Topic Cluster***

2.05

Non-Small-Cell Lung Carcinoma; Lung Neoplasms

Beijing Share of Topic Globally*

1.87%

Share of Beijing Oncology and Cancer Research**

4.5%

FWCI of Beijing Research in this Topic Cluster***

1.32

T-Lymphocytes; Immunotherapy

Beijing Share of Topic Globally*

0.97%

Share of Beijing Oncology and Cancer Research**

4.4%

FWCI of Beijing Research in this Topic Cluster***

1.44

*Total Beijing Topic Publications Divided by Total Global Topic Publications
**Total Beijing Topic Publications Divided by Total Beijing Oncology and Cancer Publications
***FWCI: Field-Weighted Citation Impact

Next 6 topic clusters by output (2010-2019)

Output
Share of Global Topic Output
FWCI
Prominence & Patients
Lymphoma; Diffuse Large B-Cell Lymphoma
466
0.9%
0.68
89.558%
Heptacellular Carcinoma; Liver
457
1.2%
0.79
84.270%
Acute Myeloid Leukemia; Precursor Cell Lymphblastic Leukima-Lymphoma
441
1.0%
0.61
89.625%
Breast Neoplasms; Mammography
405
0.8%
1.15
88.220%
Stomach Neoplasms; Esophageal Neoplasms; Gastrectomy
352
1.3%
1.17
72.088%
DNA Methylation; Epigenomics
328
2.1%
1.13
80.589%